Doyle Mittie
- SEC CIK
- 0001918845
In the past year, 12 open-market sale filings worth $2.98M and no purchases.
Current role at each company
- AVTX Avalo Therapeutics, Inc.Chief Medical Officeras of Sep 1, 2026
- CGEM Cullinan Therapeutics, Inc.Directoras of Jun 18, 2026
- DICE DICE Therapeutics, Inc.Directoras of Aug 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.98M
- 12 filings
- Net
- −$2.98M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Doyle Mittie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVTX Avalo Therapeutics, Inc.
Chief Medical Officer12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)4:38 PM ET | Aug 28 | 4 days | Doyle MittieChief Medical Officer | SSale | −679 | $20.00 | −$13.6K | −1.3%51.8K after | 10b5-1 |
| Aug 19, 2026 (view filing)4:10 PM ET | Aug 17 | 2 days | Doyle MittieChief Medical Officer | SSale | −1.00K | $20.00 | −$20.0K | −1.9%51.8K after | 10b5-1 |
| Aug 12, 2026 (view filing)4:10 PM ET | Aug 10 | 2 days | Doyle MittieChief Medical Officer | SSale | −679 | $20.00 | −$13.6K | −1.3%51.8K after | 10b5-1 |
| Jul 29, 2026 (view filing)4:05 PM ET | Jul 27 | 2 days | Doyle MittieChief Medical Officer | SSale | −1.00K | $20.00 | −$20.0K | −1.9%51.8K after | 10b5-1 |
| Jul 2, 2026 (view filing)4:05 PM ET | Jun 30 | 2 days | Doyle MittieChief Medical Officer | SSale | −4.65K | $20.00 | −$93.1K | −8.2%51.8K after | 10b5-1 |
| Jun 25, 2026 (view filing) | Jun 23 | 2 days | Doyle MittieChief Medical Officer | SSale | −1.45K | $18.00 | −$26.1K | −2.7%51.8K after | 10b5-1 |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Doyle MittieChief Medical Officer | SSale | −679 | $16.00 | −$10.9K | −1.4%47.1K after | 10b5-1 |
| May 19, 2026 (view filing) | May 15 | 4 days | Doyle MittieChief Medical Officer | SSale | −3.00K | $18.76 | −$56.3K | −45.3%3.62K after | 10b5-1 |
| May 7, 2026 (view filing) | May 5-6 | 2 days | Doyle MittieChief Medical Officer | SSale | −108.2K | $20.61 | −$2.23M | −96.8%3.62K after | 6 lots10b5-1 |
| Apr 8, 2026 (view filing) | Apr 6 | 2 days | Doyle MittieChief Medical Officer | SSale | −3.97K | $18.01 | −$71.5K | −52.3%3.62K after | 10b5-1 |